Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation

Michael T Scott1, Kimberly E Todd2, Heather Oakley2

  • 1Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center and Jackson Memorial Hospital, Miami, Florida; Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida.

Insights

A certified child life specialist (CCLS) significantly reduces daily anesthesia needs for pediatric radiation therapy patients. This leads to substantial cost savings for healthcare payers, potentially exceeding $775,000 annually for high-volume centers.

Area of Science:

  • Pediatric Oncology
  • Health Services Research
  • Child Life Services

Background:

  • Radiation therapy for pediatric patients often necessitates daily anesthesia.
  • Reducing anesthesia frequency can improve patient experience and lower healthcare costs.
  • The role of certified child life specialists (CCLS) in optimizing pediatric cancer care is increasingly recognized.

Purpose of the Study:

  • To evaluate the impact of a CCLS on the frequency of daily anesthesia in pediatric radiation therapy.
  • To quantify the potential healthcare payer cost savings associated with CCLS utilization.

Main Methods:

  • Retrospective analysis of 425 pediatric patients (aged 3-12.9 years) treated with radiation therapy between 2006-2014.
  • Comparison of daily anesthesia rates before (2006-2011) and after (2011-2014) the introduction of a CCLS.
  • Calculation of cost savings based on anesthesia charges and CCLS employment expenses.

Main Results:

  • Daily anesthesia use decreased from 57% to 40.8% in the analyzed pediatric cohort after CCLS implementation (P<.0001).
  • A >16% absolute reduction in anesthesia use translated to significant cost savings, approaching $50,000 per 6 children treated annually.
  • Projected annual healthcare system cost savings could exceed $775,000 when treating 100 children per year.

Conclusions:

  • CCLS significantly reduce the need for daily anesthesia in pediatric radiation therapy.
  • Healthcare payers can achieve substantial cost savings by supporting CCLS employment in pediatric radiation oncology centers.
  • Integrating CCLS into treatment protocols is a cost-effective strategy for improving pediatric cancer care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641